The Role of Nanoparticles in Tumor Treatment
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: 31 January 2025 | Viewed by 37
Special Issue Editor
Interests: nanotechnology; transdermal/topical systems; skin delivery; lipid nanoparticles; controlled release; brain drug delivery; cancer therapy; quality by design
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of oncology, nanotechnology, and biomedicine has witnessed rapid progress, leading to innovative developments in nanoparticles for safer and more effective cancer therapy. Nanoparticles predominantly fall into two categories: nanoparticles for gene therapy applications or for the delivery of small-molecule drugs for cancer treatment. They include liposome-, micelle- and protein-based nanoparticles and have biologically attractive properties such as biocompatibility and biodegradability. Nanomedicine could represent a step forward for the application of immunotherapies in clinical practices. By harnessing the potential of nanoparticles, this Special Issue aims to usher in a new era of precise and personalized cancer therapy, providing patients with individualized treatment options.
This Special Issue’s goal is the design, development, and characterization of biological nanoparticles and their therapeutic application in cancer. This Special Issue will cover the latest advances made in the last few years.
We look forward to receiving your contributions.
Dr. Carla Vitorino
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- cancer therapy
- nanotechnology
